Open Access<p>Is Agomelatine Associated with Less Sedative-Hypnotic Usage in Patients with Major Depressive Disorder? A Nationwide, Population-Based Study</p>
Author(s) -
Shih-Chun Hsing,
Yo-Ting Jin,
NianSheng Tzeng,
ChiHsiang Chung,
TienYu Chen,
HsinAn Chang,
YuChen Kao,
Wu-Chien Chien
Publication year - 2020
Publication title -
neuropsychiatric disease and treatment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.819
H-Index - 67
eISSN - 1178-2021
pISSN - 1176-6328
DOI - 10.2147/ndt.s257723
Subject(s) - agomelatine , medicine , sedative , sedative/hypnotic , major depressive disorder , population , pharmacoepidemiology , odds ratio , hypnotic , psychiatry , antidepressant , mood , medical prescription , pharmacology , environmental health , hippocampus
To examine the association between the usage of agomelatine in patients with major depressive disorder and the usage of sedative-hypnotics.